Minneapolis
89°F
eEdition
News & Politics
Sports
Food & Culture
Business
Outdoors
Opinion
Things To Do
Obituaries
More of What Matters to Minnesota
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Minnesota State Top Stocks
Markets
Minnesota Stocks
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
(NY:
BLCO
)
16.27
+0.28 (+1.75%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about BLCO
< Previous
1
2
3
4
5
Next >
What 4 Analyst Ratings Have To Say About Bausch & Lomb
September 12, 2022
Bausch & Lomb (NYSE:BLCO) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Expert Ratings for Bausch & Lomb
September 12, 2022
Within the last quarter, Bausch & Lomb (NYSE:BLCO) has observed the following analyst ratings:
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 12, 2022
September 12, 2022
Upgrades
Via
Benzinga
From Corporate Raider To Activist Investor: Here Are Three High-Yielding Stocks Carl Icahn Favors
August 28, 2022
Formerly known as a "corporate raider," Carl Icahn is the founder and controlling shareholder of Icahn Enterprises, which is a large holding company with well diversified positions.
Via
Benzinga
Expert Ratings for Bausch & Lomb
August 16, 2022
Bausch & Lomb (NYSE:BLCO) has observed the following analyst ratings within the last quarter:
Via
Benzinga
'Well-Established' Eye Health Company Bausch + Lomb Gets Outperform Rating From This Analyst
July 26, 2022
Via
Benzinga
Expert Ratings for Bausch & Lomb
July 26, 2022
Bausch & Lomb (NYSE:BLCO) has observed the following analyst ratings within the last quarter:
Via
Benzinga
BHC Stock Continues to Fall as Bausch Health Responds to Court Decision
July 29, 2022
Although Bausch Health promises to fight back against an unfavorable patent protection ruling, BHC stock is still hurting.
Via
InvestorPlace
Bausch Health (BHC) Stock Plunges 50% on Patent News
July 28, 2022
With Bausch Health losing a critical patent battle enabling its key drug to suffer generic competition, BHC stock veritably crumbled.
Via
InvestorPlace
Stocks That Hit 52-Week Lows On Thursday
July 28, 2022
On Thursday, 108 companies set new 52-week lows.
Via
Benzinga
IPO Market Posts Slowest Quarter Since Great Recession
June 24, 2022
IPOs in the second quarter plunged to the lowest level since the Great Recession in 2009, led by health care and technology.
Via
Investor's Business Daily
Why Shares of Solar Companies Are Trading Higher? 64 Stocks Moving In Thursday's Mid-Day Session
July 28, 2022
Gainers
Via
Benzinga
Meta, Charter Communications, Southwest Airlines And Some Other Big Stocks Moving Lower On Thursday
July 28, 2022
Bausch Health Companies Inc. (NYSE: BHC) shares fell 50.3% to $4.3166 following reports of an order on a patent litigation over Xifaxan.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 26, 2022
July 26, 2022
Upgrades
Via
Benzinga
7 Ways to Prepare for a Recession: An Investor’s Guide
June 24, 2022
There are plenty of ways to prepare for a recession. Here are seven ways you can make sure you're ready for whatever comes next.
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For June 24, 2022
June 24, 2022
Upgrades
Via
Benzinga
2 Cheap Stocks Trading at “Deal of the Century” Prices
June 10, 2022
Simple value metrics are provenly bad at generating consistent returns, but that doesn't mean there aren't opportunities to be found.
Via
InvestorPlace
Expert Ratings for Bausch & Lomb
June 09, 2022
Over the past 3 months, 7 analysts have published their opinion on Bausch & Lomb (NYSE:BLCO) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
3 Value Stocks That Could 2x in a Recession
June 02, 2022
It might be tempting to say that valuation metrics are no longer useful for certain kinds of value stocks, but you need to adjust your focus.
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For May 31, 2022
May 31, 2022
Upgrades
Via
Benzinga
The Week Ahead In Biotech (May 30-June 4): FDA Decision For Eton's Partnered Epilepsy Drug, ASCO Conference Gets Underway And More
May 30, 2022
Biotech stocks advanced in the week ended May 27, tracking the overall positive sentiment of the broader market. Notwithstanding the week's strength, the sector has been one of the worst performers for...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 11, 2022
May 11, 2022
Upgrades
Via
Benzinga
Bausch Health (BHC) Stock Plunges 25% After Bausch + Lomb IPO
May 10, 2022
Bausch Health (BHC) stock is falling on Tuesday following the release of its earnings report for the first quarter of 2022.
Via
InvestorPlace
RBC Capital: What To Expect When Bausch Health Companies Reports Q1 Tomorrow
May 09, 2022
RBC Capital Markets expects Bausch Health Companies Inc (NYSE: BHC) Q1 FY22 revenue of $2.02 billion (previous $2.04 billion; consensus $2.05 billion) and adjusted EBITDA of $799 million (previous $816...
Via
Benzinga
Opening Day: Bausch + Lomb Pops In Public Debut
May 07, 2022
Shares of Bausch + Lomb rose over 11% to end its first trading day at $20. This was the second biggest IPO of the year. Bausch + Lomb opened at $18.50 after having priced its initial public offering at...
Via
Talk Markets
BLCO Stock: 7 Things to Know About the Bausch + Lomb IPO Today
May 06, 2022
Here's what investors in Bausch + Lomb may want to know about the highly anticipated BLCO stock IPO, which took place today.
Via
InvestorPlace
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.